The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Wellplus Flavoured tablets for Dogs

150, 144, 50 mg/tablet Tablet

Divasa-Farmavic S.A.VPA10505/003/001

Main Information

Trade NameWellplus Flavoured tablets for Dogs
Active SubstancesFebantel
Pyrantel embonate
Praziquantel
Strength150, 144, 50 mg/tablet
Dosage FormTablet
Licence HolderDivasa-Farmavic S.A.
Licence NumberVPA10505/003/001

Group Information

ATC CodeQP52AA30 combinations of quinoline derivatives and related substances
Therapeutic ClassEndoparasiticide
SpeciesDogs

Status

Authorised/WithdrawnAuthorised
Licence Issued13/12/2013
Legal StatusCAM: Companion Animal Medicine as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back